Biotransformation of locally applied precursors of dopamine, serotonin and noradrenaline in striatum and hippocampus: A microdialysis study

Journal of Neural Transmission

Volumn 104, Issue 11-12, 1997, Pages 1215-1228

  Sarre, S ^a   Smolders, I ^a   Thorre K ^a   Ebinger, G ^b   Michotte, Y ^a  

^a PHARMACEUTICAL INSTITUTE   (Belgium)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Dopamine; L 5 hydroxytryptophan; L threo 3,4 dihydroxyphenylserine; Levodopa; Microdialysis; Noradrenaline; Serotonin

Indexed keywords

5 HYDROXYTRYPTOPHAN; AROMATIC LEVO AMINO ACID DECARBOXYLASE; DOPAMINE; LEVODOPA; NORADRENALIN; SEROTONIN; TETRODOTOXIN; THREO 3,4 DIHYDROXYPHENYLSERINE;

ANIMAL EXPERIMENT; ARTICLE; BIOTRANSFORMATION; CORPUS STRIATUM; DECARBOXYLATION; HIPPOCAMPUS; MALE; MICRODIALYSIS; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT;

5-HYDROXYTRYPTOPHAN; ANIMALS; BIOTRANSFORMATION; DOPAMINE; DOPAMINE AGENTS; DROXIDOPA; EXTRACELLULAR SPACE; HIPPOCAMPUS; LEVODOPA; MALE; MICRODIALYSIS; MICROINJECTIONS; NEOSTRIATUM; NOREPINEPHRINE; RATS; RATS, WISTAR; SEROTONIN; SODIUM CHANNEL BLOCKERS; TETRODOTOXIN;

EID: 0031434735     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01294722     Document Type: Article

References (41)

1. Abercrombie ED, Keller RW, Zigmond MJ (1988) Characterization of hippocampal norepinephrine release as measured by microdialysis perfusion: pharmacological and behavioural studies. Neuroscience 27: 897-904
2. Aston-Jones G (1985) Behavioral functions of locus coeruleus derived from cellular attributes. Physiol Psychol 13: 118-126
3. Auerbach SB, Minzenberg MJ, Wilkinson LO (1989) Extracellular serotonin and 5-hydroxyindoleacetic acid in hypothalamus of the unanaesthetized rat measured by in vivo dialysis coupled to high-performance liquid chromatography with electro-chemical detection-dialysate serotonin reflects neuronal release. Brain Res 499: 281-290
4. Bartholini G, Constantinidis J, Puig M, Tissot R, Pletscher A (1975) The stereo-isomers of 3,4-dihydroxyphenylserine as precursor of norepinephrine. J Pharmacol Exp Ther 193: 523-532
5. Blaschko H, Chrusciel TL (1960) The decarboxylation of amino acids related to tyrosine and their awakening action in reserpine-treated mice. J Physiol 151: 272-284
6. Björklund A, Lindvall O (1984) Dopamine-containing systems in the CNS. In: Björklund A, Hökfelt T (eds) Handbook of chemical neuroanatomy, vol 2. Elsevier, Amsterdam, pp 55-122
7. Byerley WF, Risch SC (1985) Depression and serotonin metabolisms: rationale for neurotransmitter precursor treatment. J Clin Psychopharmacol 5: 191-206
8. Carboni E, Di Chiara G (1989) Serotonin release estimated by transcortical dialysis in freely moving rats. Neuroscience 32: 37-645
9. Dahlström A, Fuxe K (1964) Evidence for the existence of monoamine neurons in the central nervous system. I. Demonstration of monoamines in cell bodies of brain stem neurons. Acta Physiol Scand 62 [Suppl 232]: 1-55
10. Di Chiara G (1990) In vivo brain dialysis of neurotransmitters. Trends Pharmacol Sci 11: 116-121
11. Ehringer H, Hornykiewicz O (1960) Verteilung Noradrenalin und Dopamin im Gehirm des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems. Wien Klin Wochenschr 72: 1236-1239
12. Grahame-Smith DG (1974) How important is the synthesis of brain 5-hydroxytryptamine in the physiological control of its central function? Adv Biochem Psychopharmacol 10: 83-87
13. Hornykiewicz O (1966) Dopamine (3-hydroxytyramine) and brain function. Pharmacol Rev 18: 925-962
14. Jones BE, Moore RY (1977) Ascending projections of the locus coeruleus in the rat. II. Autoradiographic study. Brain Res 127: 23-53
15. Klawans Jr HL, Goetz C, Westeimer R (1972) Pathophysiology of schizophrenia and the striatum. Dis Nerv Syst 33: 711-719
16. Kreiss DS, Wieland S, Lucki I (1993) The presence of a serotonin uptake inhibitor alters pharmacological manipulations of serotonin release. Neuroscience 52: 295-301
17. Kuhn DM, Wolf WA, Youdim MBH (1986) Review: serotonin neurochemistry revisited: a new look at some old axioms. Neurochem Int 8: 141-154
18. L'Heureux R, Dennis T, Curet O, Scatton B (1986) Measurement of endogenous noradrenaline release in the rat cerebral cortex in vivo by transcortical dialysis: effects of drugs affecting noradrenergic transmission. J Neurochem 46: 1794-1801
19. Maruyama W, Nakahara D, Naoi M (1994) A new metabolic pathway of L-threo-3,4-dihydroxyphenylserine, a precursor amino acid of norepinephrine, in the brain. Studies by in vivo microdialysis. J Neural Transm [P-D Sect] 7: 21-33
20. Maruyama W, Naoi M, Narabayashi H (1996) The metabolism of L-DOPA and L-threo-3,4-dihydroxyphenylserine and their effects on monoamines in the human brain: analysis of the intraventricular fluid from parkinsonian patients. J Neurol Sci 139: 141-148
21. Matsumoto M, Yoshioka M, Togashi H, Hirokami M, Tichihara M, Ikeda T, Smith CB, Saito H (1994) Mu-Opioid receptors modulate noradrenaline release from the rat hippocampus as measured by brain microdialysis. Brain Res 636: 1-8
22. Meltzer HY, Stahl SM (1976) The dopamine hypothesis of schizophrenia: a review. Schizophr Bull 2: 19-76
23. Narabayashi H (1984) Akinesia in parkinsonism - clinical and pharmacological analysis of parkinsonian symptoms. Bull Acad Med Bel 139: 309-320
24. Narabayashi H, Kondo T, Hayashi A, Suzuki T, Nagatsu T (1981) L-Threo-3,4-dihydroxyphenylserine treatment for akinesia and freezing of parkinsonism. Proc Jpn Acad Ser B 57: 351-354
25. Narabayashi H, Kondo T, Yokochi F, Nagatsu T (1986) Clinical effects of L-threo-3,4-dihydroxyphenyl serine in cases of Parkinsonism and pure akinesia. In: Yahr MD, Bergman KJ (eds) Advances in neurology 45. Raven Press, New York, pp 593-602
26. Pickel VM, Segal M, Bloom FE (1974) A autoradiographic study of the efferent pathways of the nucleus locus coeruleus. J Comp Neurol 155: 15-42
27. Sarre S, Herregodts P, Deleu D, De Klippel N, Ebinger G, Michotte Y (1992a) High-Performance Liquid Chromatography with electrochemical detection for the determination of levodopa, catecholamines and their metabolites in rat brain dialysates. J Chromatogr Biomed Appl 575: 207-212
28. Sarre S, Marvin CA, Ebinger G, Michotte Y (1992b) Microbore liquid chromato graphy with electrochemical detection for the determination of serotonin and 5-hydroxyindoleacetic acid in rat brain dialysates. J Chromatogr Biomed Appl 582: 29-34
29. Sarre S, Herregodts P, Ebinger G, Michotte Y (1994) Biotransformation of locally applied L-DOPA in striatum of hemi-Parkinson rats studied with microdialysis. Naunyn Schmiedebergs Arch Pharmacol 350: 15-21
30. Sarre S, Ebinger G, Michotte Y (1996) Levodopa biotransformation in hemi-Parkinson rats: effect of dopamine receptor agonists and antagonists. Eur J Pharmacol 296: 247-260
31. Sharp T, Bramwell SR, Clark D, Grahame-Smith DG (1989) In vivo measurement of extracellular 5-hydroxytryptamine in hippocampus of the anaesthetized rat using microdialysis: changes in relation to 5-hydroxytryptaminergic neuronal activity. J Neurochem 53: 234-240
32. Smolders I, Khan GM, Manil J, Ebinger G, Michotte Y (1997) NMDA-receptor-mediated pilocarpine-induced seizures: characterization in freely moving rats using microdialysis. Br J Pharmacol 121: 1171-1179
33. Sumi C, Ichinose H, Nagatsu T (1990) Characterization of recombinant human aromatic L-amino acid decarboxylase expressed in COS cells. J Neurochem 55: 1075-1078
34. Thorré K, Sarre S, Twahirwa E, Meeusen R, Ebinger G, Haemers A, Michotte Y (1996) Effect of L-tryptophan, L-5-hydroxytryptophan and L-tryptophan prodrugs on the extracellular levels of 5-HT and 5-HIAA in the hippocampus of the rat using microdialysis. Eur J Pharmac Sci 4: 247-256
35. Thorré K, Sarre S, Ebinger G, Michotte Y (1997) Characterization of extracellular serotonin release in the substantia nigra of freely moving rat using microdialysis. Brain Res (in press)
36. Ungerstedt U (1971) Stereotaxic mapping of the monoamine pathway in the rat brain. Acta Physiol Scand 367: 1-48
37. Van Veldhuizen MJA, Feenstra MGP, Boer GJ, Westerink BHC (1990) Microdialysis studies on cortical noradrenaline release: basic characteristics, significance of extracellular calcium and massive post-mortem increase. Neurosci Lett 119: 233-236
38. Verhagen-Kamerbeek WDJ, De Haas JRA, Teelken AW, Lakke JPWF (1991) In vivo assessment of the efficacy of L-threo-DOPS in producing extracellular noradrenaline in the CNS. In: Rollema H, Westerink BHC, Drijfhout WJ (eds) Monitoring molecules in neuroscience. University Centre for Pharmacy, Groningen, pp 409-412
39. Westerink BHC, De Vries J (1988) Characterization of in vivo dopamine release as determined by brain microdialysis after acute and subchronic implantations: methodological aspects. J Neurochem 51: 683-687
40. Wolf WA, Youdim MBH, Kuhn DM (1985) Does brain 5HIAA indicate serotonin release or monoamine oxidase activity? Eur J Pharmacol 109: 381-383
41. Zetterström T, Sharp T, Collin AK, Ungerstedt U (1988) In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC. Eur J Pharmacol 148: 327-334